Thrombotic events in metastatic colorectal cancer patients treated with leucovorin, fluorouracil and irinotican (FOLFIRI) plus bevacizumab Humaid O. Al-Shamsi1,2,3, Abdulaziz Al Farsi1, Mahraz Anjum2, Hua Shen2, Kevin Zbuk1, Richard J. Cook2, Lori-Ann Linkins4, Pierre Major1 1Department of Oncology, McMaster University, Hamilton, Ontario, Canada; 2Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada;